Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 101–200 of 1,000
The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF
Sadat, S., Gehmert, S., Song, Y.-H., Yen, Y., Bai, X., Gaiser, S., Klein, H., & Alt, E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.058 · Cited by 300
Cell-Based Therapy of Myocardial Infarction
Dimmeler, S., Burchfield, J., & Zeiher, A. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155317 · Cited by 302
Natural history of mesenchymal stem cells, from vessel walls to culture vessels
Murray, I. R., West, C. C., Hardy, W. R., James, A. W., Park, T. S., Nguyen, A., Tawonsawatruk, T., Lazzari, L., Soo, C., & Péault, B. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1462-6 · Cited by 291
“As such, transplanted MSCs may exert beneficial effects through their vast secretome beyond immune regulation [60, 61].”
BackgroundThe wound-healing and antioxidant effects of adipose-derived stem cells
Kim, W.-S., Park, B.-S., & Sung, J.-H. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903039684 · Cited by 294
“The paracrine mechanism of stem cells has been well reported in cardiovascular and neurodegenerative diseases [34-36].”
BackgroundTakahashi, M., Li, T.-S., Suzuki, R., Kobayashi, T., Ito, H., Ikeda, Y., Matsuzaki, M., & Hamano, K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00142.2006 · Cited by 293
Qiu, G., Zheng, G., Ge, M., Wang, J., Huang, R., Shu, Q., & Xu, J. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1069-9 · Cited by 289
Gnecchi, M., & Melo, L. G. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-060-7_18 · Cited by 285
Self-citationRota, M., Padin-Iruegas, M. E., Misao, Y., De Angelis, A., Maestroni, S., Ferreira-Martins, J., Fiumana, E., Rastaldo, R., Arcarese, M. L., Mitchell, T. S., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.178525 · Cited by 280
Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology
Hodgkinson, C. P., Bareja, A., Gomez, J. A., & Dzau, V. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.305373 · Cited by 273
Self-citationOphelders, D. R. M. G., Wolfs, T. G. A. M., Jellema, R. K., Zwanenburg, A., Andriessen, P., Delhaas, T., Ludwig, A.-K., Radtke, S., Peters, V., Janssen, L., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0197 · Cited by 278
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21
Wang, K., Jiang, Z., Webster, K. A., Chen, J., Hu, H., Zhou, Y., Zhao, J., Wang, L., Wang, Y., Zhong, Z., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0386 · Cited by 274
Self-citationTrophic Effects of Mesenchymal Stem Cells in Tissue Regeneration
Fu, Y., Karbaat, L., Wu, L., Leijten, J., Both, S. K., & Karperien, M. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0365 · Cited by 276
Bjørge, I. M., Kim, S. Y., Mano, J. F., Kalionis, B., & Chrzanowski, W. (2018) · Biomaterials Science · doi:10.1039/c7bm00479f · Cited by 275
Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart
Oshima, Y., Ouchi, N., Sato, K., Izumiya, Y., Pimentel, D. R., & Walsh, K. (2008) · Circulation · doi:10.1161/circulationaha.108.767673 · Cited by 275
Drommelschmidt, K., Serdar, M., Bendix, I., Herz, J., Bertling, F., Prager, S., Keller, M., Ludwig, A.-K., Duhan, V., Radtke, S., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.11.011 · Cited by 269
Jiang, D., Gao, F., Zhang, Y., Wong, D. S. H., Li, Q., Tse, H.-F., Xu, G., Yu, Z., & Lian, Q. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.358 · Cited by 267
Trophic Effects of Mesenchymal Stem Cells Increase Chondrocyte Proliferation and Matrix Formation
Wu, L., Leijten, J. C. H., Georgi, N., Post, J. N., van Blitterswijk, C. A., & Karperien, M. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0517 · Cited by 267
Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells
Sze, S. K., de Kleijn, D. P. V., Lai, R. C., Khia Way Tan, E., Zhao, H., Yeo, K. S., Low, T. Y., Lian, Q., Lee, C. N., Mitchell, W., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600393-mcp200 · Cited by 265
Cho, H.-J., Lee, N., Lee, J. Y., Choi, Y. J., Ii, M., Wecker, A., Jeong, J.-O., Curry, C., Qin, G., & Yoon, Y.-S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070166 · Cited by 264
VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart
Tang, J.-M., Wang, J.-N., Zhang, L., Zheng, F., Yang, J.-Y., Kong, X., Guo, L.-Y., Chen, L., Huang, Y.-Z., Wan, Y., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr053 · Cited by 259
“Recent studies have shown that paracrine release of SDF-1a/ CXCR4 by Akt or IGF-1-modified MSC promotes myocardial repair.(18,20,31) IGF-1 has been reported to stimulate VEGF expression in endothelial cells.”
Self-citationMicrovesicles and exosomes for intracardiac communication
Sluijter, J. P. G., Verhage, V., Deddens, J. C., van den Akker, F., & Doevendans, P. A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu022 · Cited by 254
Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Satija, N. K., Singh, V. K., Verma, Y. K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R. P., & Gurudutta, G. U. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00857.x · Cited by 252
“4392 differentiated into cardiomyocytes, the reduction in infarct size and improvement in cardiac function were possibly mediated by secreted paracrine factors [117].”
BackgroundImmunomodulation of activated hepatic stellate cells by mesenchymal stem cells
Parekkadan, B., van Poll, D., Megeed, Z., Kobayashi, N., Tilles, A. W., Berthiaume, F., & Yarmush, M. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.150 · Cited by 252
“In particular, studies using MSCs for cellular cardiomyoplasty showed that paracrine factors produced by MSCs may contribute to their therapeutic benefit [11].”
BackgroundAutologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp265 · Cited by 253
An emerging consensus on cardiac regeneration
van Berlo, J. H., & Molkentin, J. D. (2014) · Nature Medicine · doi:10.1038/nm.3764 · Cited by 244
Cell therapy for the treatment of coronary heart disease: a critical appraisal
Wollert, K. C., & Drexler, H. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.1 · Cited by 251
“Genetic modification could also be used to maintain the functionality of cells, including their capacity to secrete paracrine mediators”
MethodGalderisi, U., Peluso, G., & Di Bernardo, G. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10231-w · Cited by 240
Park, J., Kim, B., Han, J., Oh, J., Park, S., Ryu, S., Jung, S., Shin, J.-Y., Lee, B. S., Hong, B. H., et al. (2015) · ACS Nano · doi:10.1021/nn507149w · Cited by 243
Huang, J., Zhang, Z., Guo, J., Ni, A., Deb, A., Zhang, L., Mirotsou, M., Pratt, R. E., & Dzau, V. J. (2010) · Circulation Research · doi:10.1161/circresaha.109.196030 · Cited by 240
Self-citationMyocardial AKT: The Omnipresent Nexus
Sussman, M. A., Völkers, M., Fischer, K., Bailey, B., Cottage, C. T., Din, S., Gude, N., Avitabile, D., Alvarez, R., Sundararaman, B., et al. (2011) · Physiological Reviews · doi:10.1152/physrev.00024.2010 · Cited by 229
Müller-Ehmsen, J., Krausgrill, B., Burst, V., Schenk, K., Neisen, U. C., Fries, J. W. U., Fleischmann, B. K., Hescheler, J., & Schwinger, R. H. G. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.07.023 · Cited by 234
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J.-D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003474 · Cited by 234
“To explain this disparity, the improvement in cardiac function may be due to paracrine factors, as suggested by Dzau and colleagues [30,31,32].”
BackgroundCARDIAC REGENERATION: Repopulating the Heart
Rubart, M., & Field, L. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124530 · Cited by 235
Ohnishi, S., Yasuda, T., Kitamura, S., & Nagaya, N. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0347 · Cited by 222
Chen, C. W., Wang, L. L., Zaman, S., Gordon, J., Arisi, M. F., Venkataraman, C. M., Chung, J. J., Hung, G., Gaffey, A. C., Spruce, L. A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy067 · Cited by 218
“Nevertheless, recent studies have demonstrated the persistence of the therapeutic effect of myocardially transplanted cells in the absence of cell engraftment, suggesting the potential for paracrine mechanisms derived from the cell secretome as the therapeutic mediators.(6,7) Extracellular vesicles (EVs), including ex…”
BackgroundMyeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction
Korf-Klingebiel, M., Reboll, M. R., Klede, S., Brod, T., Pich, A., Polten, F., Napp, L. C., Bauersachs, J., Ganser, A., Brinkmann, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3778 · Cited by 227
Ohnishi, S., Sumiyoshi, H., Kitamura, S., & Nagaya, N. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.028 · Cited by 219
“through paracrine actions such as angiogenic, anti-apoptotic, and anti-inflammatory effects [2,3,5–10].”
BackgroundMesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
Porada, C. D., & Almeida-Porada, G. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.010 · Cited by 223
Mazo, M., Planat-Bénard, V., Abizanda, G., Pelacho, B., Léobon, B., Gavira, J. J., Peñuelas, I., Cemborain, A., Pénicaud, L., Laharrague, P., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.03.017 · Cited by 218
“New strategies to achieve more efficient engraftment and to prevent apoptosis [43–46] are now required.”
BackgroundPadin-Iruegas, M. E., Misao, Y., Davis, M. E., Segers, V. F. M., Esposito, G., Tokunou, T., Urbanek, K., Hosoda, T., Rota, M., Anversa, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.852285 · Cited by 217
Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application
Ceccarelli, S., Pontecorvi, P., Anastasiadou, E., Napoli, C., & Marchese, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00236 · Cited by 212
“…applications (Hashemi et al., 2008; Cai et al., 2009; Madonna et al., 2009; Bai et al., 2010; Grimaldi et al., 2013; Sommese et al., 2017), due to both stimulation of angiogenesis and potent anti-inflammatory paracrine effect eventually favoring the cardiac healing process (Gnecchi et al., 2005).”
BackgroundHe, W., Zhang, L., Ni, A., Zhang, Z., Mirotsou, M., Mao, L., Pratt, R. E., & Dzau, V. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004708107 · Cited by 216
“Wepostulated that thebeneficial effects ofAkt-MSCare paracrine in nature (2, 3) and identified Sfrp2 as a key factor released by Akt-MSC–mediating myocardial survival and repair (4).”
BackgroundSelf-citationPlatelets in tissue repair: control of apoptosis and interactions with regenerative cells
Gawaz, M., & Vogel, S. (2013) · Blood · doi:10.1182/blood-2013-05-468694 · Cited by 210
“After myocardial infarction and intramyocardial,(30) intracoronary,(31) or intravenous(32) transplantation of MSCs, the cells have been shown to migrate toward the injured heart, prevent ventricular remodeling, and significantly restore cardiac function.(33) Various clinical studies could confirm beneficial effects of…”
BackgroundExosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
Luther, K. M., Haar, L., McGuinness, M., Wang, Y., Lynch IV, T. L., Phan, A., Song, Y., Shen, Z., Gardner, G., Kuffel, G., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.04.012 · Cited by 212
Cai, L., Johnstone, B. H., Cook, T. G., Liang, Z., Traktuev, D., Cornetta, K., Ingram, D. A., Rosen, E. D., & March, K. L. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0388 · Cited by 211
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities
Nagelkerke, A., Ojansivu, M., van der Koog, L., Whittaker, T. E., Cunnane, E. M., Silva, A. M., Dekker, N., & Stevens, M. M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.013 · Cited by 208
“2 acute myocardial infarction model [12].”
BackgroundFormiga, F. R., Pelacho, B., Garbayo, E., Abizanda, G., Gavira, J. J., Simon-Yarza, T., Mazo, M., Tamayo, E., Jauquicoa, C., & Ortiz-de-Solorzano, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.097 · Cited by 205
“In the case of cell therapy, the current view suggests that stem cells contribute to cardiac repair through a paracrine effect associated with the release of growth factors rather than by directly contributing to tissue regeneration [10-14].”
BackgroundMazhari, R., & Hare, J. M. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0770 · Cited by 210
Tsai, P.-C., Fu, T.-W., Chen, Y.-M. A., Ko, T.-L., Chen, T.-H., Shih, Y.-H., Hung, S.-C., & Fu, Y.-S. (2009) · Liver Transplantation · doi:10.1002/lt.21715 · Cited by 206
“In the acute phase of ischemic injury, moreover, bone marrow mesenchymal stem cells used for cellular cardiomyoplasty produce soluble molecules that inhibit hypoxia-induced apoptosis of cardiomyocytes.(42,43) Taken together, these studies suggest that mesenchymal stem cells can independently modulate the immune respon…”
BackgroundMicroneedle system for tissue engineering and regenerative medicine
Zhang, Y., Xu, Y., Kong, H., Zhang, J., Chan, H. F., Wang, J., Shao, D., Tao, Y., & Li, M. (2023) · Exploration · doi:10.1002/exp.20210170 · Cited by 200
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms
Segers, V. F. M., Van Riet, I., Andries, L. J., Lemmens, K., Demolder, M. J., De Becker, A. J. M. L., Kockx, M. M., & De Keulenaer, G. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00523.2005 · Cited by 204
“Moreover, MSCs have been shown to increase neovascularization (24) and to mediate paracrine effects (9, 28).”
BackgroundKorf-Klingebiel, M., Kempf, T., Sauer, T., Brinkmann, E., Fischer, P., Meyer, G. P., Ganser, A., Drexler, H., & Wollert, K. C. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn456 · Cited by 203
“Cytoprotective effects may salvage cardiomyocytes at risk and lead to a reduction in infarct size.(15,27,28) In one clinical trial, improvements in left ven-”
Transplantation of Cord Blood Mesenchymal Stem Cells as Spheroids Enhances Vascularization
Bhang, S. H., Lee, S., Shin, J.-Y., Lee, T.-J., & Kim, B.-S. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0640 · Cited by 204
Mias, C., Trouche, E., Seguelas, M.-H., Calcagno, F., Dignat-George, F., Sabatier, F., Piercecchi-Marti, M.-D., Daniel, L., Bianchi, P., Calise, D., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1000 · Cited by 203
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
Haider, H. K., & Ashraf, M. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.004 · Cited by 201
“Later studies from the same research group showed that Aktmodified mesenchymal stem cells released paracrine factors which immensely contributed towards host myocyte survival and functional recovery of the infarcted heart [14].”
BackgroundResultVrijsen, K. R., Maring, J. A., Chamuleau, S. A. J., Verhage, V., Mol, E. A., Deddens, J. C., Metz, C. H. G., Lodder, K., van Eeuwijk, E. C. M., van Dommelen, S. M., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600308 · Cited by 204
Kalervo Väänänen, H. (2005) · Annals of Medicine · doi:10.1080/07853890500371957 · Cited by 197
“Thirdly, more recent studies have suggested that the protective effect of MSC in myocardial infarction is mainly due to their paracrine effects, meaning that transplanted cells secrete soluble factors that are able to protect cells from tissue damage (80,81).”
Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis
Kwon, H. M., Hur, S.-M., Park, K.-Y., Kim, C.-K., Kim, Y.-M., Kim, H.-S., Shin, H.-C., Won, M.-H., Ha, K.-S., Kwon, Y.-G., et al. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.06.004 · Cited by 198
“It has been shown that the therapeutic effects ofMSCs are at leastmediated by paracrine tropic factors secreted by cells [10,11].”
BackgroundInfluentialOhnishi, S., Yanagawa, B., Tanaka, K., Miyahara, Y., Obata, H., Kataoka, M., Kodama, M., Ishibashi-Ueda, H., Kangawa, K., Kitamura, S., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.10.003 · Cited by 196
“Furthermore, a recent study demonstrated that conditioned medium obtained from MSC culture had cardioprotective effect [26].”
BackgroundRethinking Regenerative Medicine: A Macrophage-Centered Approach
Brown, B. N., Sicari, B. M., & Badylak, S. F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00510 · Cited by 187
Analysis of Allogenicity of Mesenchymal Stem Cells in Engraftment and Wound Healing in Mice
Chen, L., Tredget, E. E., Liu, C., & Wu, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007119 · Cited by 190
“Previous studies suggest that the therapeutic effect of BM-MSCs in acute myocardial infarction occurs early within days following implantation which may largely be attributed to paracrine factors released by the cells [33,34].”
Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing
Chamberlain, C. S., Clements, A. E. B., Kink, J. A., Choi, U., Baer, G. S., Halanski, M. A., Hematti, P., & Vanderby, R. (2019) · Stem Cells · doi:10.1002/stem.2988 · Cited by 190
In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function
Xu, M., Uemura, R., Dai, Y., Wang, Y., Pasha, Z., & Ashraf, M. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.10.009 · Cited by 191
“It has been reported that BMSCs secrete a wide array of cytokines which may protect target cells [12,13].”
BackgroundLee, J.-R., Park, B.-W., Kim, J., Choo, Y. W., Kim, H. Y., Yoon, J.-K., Kim, H., Hwang, J.-W., Kang, M., Kwon, S. P., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz0952 · Cited by 189
“It has been revealed that implanted MSCs mediate cardiac repair mainly by secreting paracrine molecules rather than differentiating into cardiac cell lineages ( 9 ).”
Jiang, M. H., Cai, B., Tuo, Y., Wang, J., Zang, Z. J., Tu, X., Gao, Y., Su, Z., Li, W., Li, G., et al. (2014) · Cell Research · doi:10.1038/cr.2014.149 · Cited by 193
Immune regulation by mesenchymal stem cells: two sides to the coin
Stagg, J. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00739.x · Cited by 189
Fujita, Y., Kadota, T., Araya, J., Ochiya, T., & Kuwano, K. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100355 · Cited by 188
“In recent years, studies have shown that MSCs can also achieve a therapeutic effect in vivo via direct differentiation and paracrine action [11,12].”
BackgroundTsuji, H., Miyoshi, S., Ikegami, Y., Hida, N., Asada, H., Togashi, I., Suzuki, J., Satake, M., Nakamizo, H., Tanaka, M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.205260 · Cited by 184
Chung, E. S., Miller, L., Patel, A. N., Anderson, R. D., Mendelsohn, F. O., Traverse, J., Silver, K. H., Shin, J., Ewald, G., Farr, M. J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv254 · Cited by 178
“Secreted factors from the cells rather than the cells themselves, lead to stimulation of native repair.(20,22)”
BackgroundXu, Y., Shi, T., Xu, A., & Zhang, L. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12651 · Cited by 180
“Akt-modified MSCs were reported to have enhanced paracrine action [16], while overexpression of the antiapoptotic Bcl-2 inhibited apoptosis of MSCs and increased their engraftment [23].”
BackgroundMethodInfluentialSelf-citationBari, E., Perteghella, S., Di Silvestre, D., Sorlini, M., Catenacci, L., Sorrenti, M., Marrubini, G., Rossi, R., Tripodo, G., Mauri, P., et al. (2018) · Cells · doi:10.3390/cells7110190 · Cited by 176
“century when, for the first time, Gnecchi and colleagues showed that MSCs mediate their therapeutic effects by the release of paracrine factors (known as secretome) [4].”
BackgroundLuger, D., Lipinski, M. J., Westman, P. C., Glover, D. K., Dimastromatteo, J., Frias, J. C., Albelda, M. T., Sikora, S., Kharazi, A., Vertelov, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310599 · Cited by 173
Cellular Encapsulation Enhances Cardiac Repair
Levit, R. D., Landázuri, N., Phelps, E. A., Brown, M. E., García, A. J., Davis, M. E., Joseph, G., Long, R., Safley, S. A., Suever, J. D., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000367 · Cited by 174
“They possess the ability to differentiate into endothelial cells and cardiomyocytes, but likely have a greater effect through paracrine mechanisms.(4) hMSCs are highly secretory, producing a variety of immune modulatory, proangiogenic, and antiapoptotic growth factors and cytokines that act in a paracrine manner to pr…”
BackgroundImaging Survival and Function of Transplanted Cardiac Resident Stem Cells
Li, Z., Lee, A., Huang, M., Chun, H., Chung, J., Chu, P., Hoyt, G., Yang, P., Rosenberg, J., Robbins, R. C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.036 · Cited by 179
Engineered heart muscle allografts for heart repair in primates and humans
Jebran, A., Seidler, T., Tiburcy, M., Daskalaki, M., Kutschka, I., Fujita, B., Ensminger, S., Bremmer, F., Moussavi, A., Yang, H.-X., et al. (2025) · Nature · doi:10.1038/s41586-024-08463-0 · Cited by 168
“The observed therapeutic effects in xenograft models, but also in allograft adult stem cell studies with no evidence for remusculariza-tion and limited retention, suggest that the outcomes in these studies are at least partially mediated by immune responses 20 or paracrine mechanisms 21,22 .”
Self-citationStem Cell Therapy for Cardiac Repair: Ready for the Next Step
Boyle, A. J., Schulman, S. P., & Hare, J. M. (2006) · Circulation · doi:10.1161/circulationaha.105.590653 · Cited by 175
Banerjee, M. N., Bolli, R., & Hare, J. M. (2018) · Circulation Research · doi:10.1161/circresaha.118.311217 · Cited by 173
Martin‐Rendon, E., Sweeney, D., Lu, F., Girdlestone, J., Navarrete, C., & Watt, S. M. (2008) · Vox Sanguinis · doi:10.1111/j.1423-0410.2008.01076.x · Cited by 175
The tissue origin effect of extracellular vesicles on cartilage and bone regeneration
Li, Q., Yu, H., Sun, M., Yang, P., Hu, X., Ao, Y., & Cheng, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.039 · Cited by 172
Duran, J. M., Makarewich, C. A., Sharp, T. E., Starosta, T., Zhu, F., Hoffman, N. E., Chiba, Y., Madesh, M., Berretta, R. M., Kubo, H., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301202 · Cited by 171
Herrmann, J. L., Wang, Y., Abarbanell, A. M., Weil, B. R., Tan, J., & Meldrum, D. R. (2010) · Shock · doi:10.1097/shk.0b013e3181b7d137 · Cited by 170
“growth factors that promote cell survival and modulate the local inflammatory reaction (12, 14).”
BackgroundExtracellular vesicles as modulators of wound healing
Cabral, J., Ryan, A. E., Griffin, M. D., & Ritter, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.018 · Cited by 170
“Interestingly, it has been repeatedly demonstrated that the beneficial effects of MSC result – at least in part – from their secreted products in a paracrine fashion, which could be mediated via extracellular vesicles (EVs) [17-20].”
Identifying the Therapeutic Significance of Mesenchymal Stem Cells
Mishra, V. K., Shih, H.-H., Parveen, F., Lenzen, D., Ito, E., Chan, T.-F., & Ke, L.-Y. (2020) · Cells · doi:10.3390/cells9051145 · Cited by 162
“In this in vitro experiment, Akt-MSCs-derived conditioned medium collected from hypoxic Akt-MSCs was found to be efficiently protective to cardiomyocytes by inhibiting the apoptosis.”
BackgroundAge-related changes in rat bone-marrow mesenchymal stem cell plasticity
Asumda, F. Z., & Chase, P. B. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-44 · Cited by 168
“The neovascularization and angiogenesis effects of BM-MSCs are enhanced by the presence of specific growth and cytokine factors [17,18,27].”
BackgroundMethodology, biology and clinical applications of mesenchymal stem cells
Meirelles, L. D. S. (2009) · Frontiers in Bioscience · doi:10.2741/3528 · Cited by 169
Regeneration Next: Toward Heart Stem Cell Therapeutics
Hansson, E. M., Lindsay, M. E., & Chien, K. R. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.004 · Cited by 166
Perspectives on Trypanosoma cruzi–Induced Heart Disease (Chagas Disease)
Tanowitz, H. B., Machado, F. S., Jelicks, L. A., Shirani, J., de Carvalho, A. C. C., Spray, D. C., Factor, S. M., Kirchhoff, L. V., & Weiss, L. M. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.02.001 · Cited by 165
“Since then the beneficial effects of cell therapies using BMderived cells in heart disease have been increasingly attributed to paracrine effects [85–87].”
BackgroundCell-Based Therapy for Myocardial Ischemia and Infarction: Pathophysiological Mechanisms
Laflamme, M. A., Zbinden, S., Epstein, S. E., & Murry, C. E. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092038 · Cited by 164
Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis
Burchfield, J. S., & Dimmeler, S. (2008) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-1-4 · Cited by 163
“The overexpression of the survival protein Akt in MSCs led to a decrease in cardiac myocyte apoptosis in vitro and their myocardial transplantation led to a decrease in infarct size [41-44].”
BackgroundGingiva-Derived Mesenchymal Stem Cell-Mediated Therapeutic Approach for Bone Tissue Regeneration
Wang, F., Yu, M., Yan, X., Wen, Y., Zeng, Q., Yue, W., Yang, P., & Pei, X. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0523 · Cited by 160
Gunawardena, T. N. A., Rahman, M. T., Abdullah, B. J. J., & Kasim, N. H. A. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2806 · Cited by 172
Ranghino, A., Cantaluppi, V., Grange, C., Vitillo, L., Fop, F., Biancone, L., Deregibus, M. C., Tetta, C., Segoloni, G. P., & Camussi, G. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500110 · Cited by 169
“Nevertheless, some studies have demonstrated that a transient localization of stem cells in injured tissues might be sufficient to induce functional and regenerative events suggesting the release of paracrine mediators (8-12).”
BackgroundSerum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic
Oskowitz, A., McFerrin, H., Gutschow, M., Carter, M. L., & Pochampally, R. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.01.004 · Cited by 159
Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles
Giebel, B., Kordelas, L., & Börger, V. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.09.06 · Cited by 169
“Indeed, different labs recovered cardioprotective activities in MSC conditioned media (57-59).”
BackgroundThe effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model
LIM, S., KIM, Y., AHN, Y., JEONG, M., HONG, M., JOO, S., NAM, K., CHO, J., KANG, P., & PARK, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.016 · Cited by 159
Amado, L. C., Schuleri, K. H., SALIARIS, A. P., Boyle, A., Helm, R. H., Oskouei, B. N., Centola, M., Eneboe, V., Young, R. G., Lima, J. A. C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.073 · Cited by 159
Tang, X., Sun, X., Huang, K.-M., Zhang, L., Yang, Z., Zou, D., Wang, B., Warnock, G. L., Dai, L., & Luo, J. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6175 · Cited by 167
“demonstrated that CM from genetically engineered MSCs cultured in vitro have an efficacy comparable to that of cell transplantation in preventing ventricular remodeling [100].”
BackgroundSelf-citationManufacturing of human placenta‐derived mesenchymal stem cells for clinical trials
Brooke, G., Rossetti, T., Pelekanos, R., Ilic, N., Murray, P., Hancock, S., Antonenas, V., Huang, G., Gottlieb, D., Bradstock, K., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07492.x · Cited by 158
“Recent studies implicate stimulation (often termed paracrine) of neovascularisation and protection from ischaemia-induced apoptosis (Gnecchi et al, 2005; Jiang et al, 2006).”
Background
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.